GL1X · GenesisL1 explorer

MolNFT v1 · #4839 · protein

Plasma beta antithrombin-III

1E04: “Plasma beta antithrombin-III”. X-ray diffraction, 4 ligands (NAG, MAN, BMA), 7 pockets (best druggability 0.76). MolNFT v1 #4839 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1E04
Type
protein
Length
815 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Antithrombin-III
UniProt
P01008
Ligands
NAG, MAN, BMA, PO4
Pockets
7 · best druggability 0.76

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
IAntithrombin-IIIprotein40330% helix, 32% strandP01008
LAntithrombin-IIIprotein41229% helix, 33% strandP01008

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 12 copies · chains I, L
  • MAN · alpha-D-mannopyranose · sugar · 3 copies
  • BMA · beta-D-mannopyranose · sugar · 2 copies
  • PO4 · Phosphate ion · ion · chains L
  • GOL · Glycerol · additive · 2 copies · chains I, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15550.760.8355empty
21230.670.8920GOL
31330.670.8820GOL
42050.530.7829empty
51080.380.7520empty

Interfaces

1 interface between chains.

  • I–L · 938 Ų buried · 17 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 6 glycan (disulfide, N-glycosylation).

Compared structures

  • 1E04 · Plasma beta antithrombin-III · the same entry in another collection · chain I against I, TM-score 1.00
  • P01008 · AlphaFold monomer V2.0 prediction for antithrombin-III (P01008) · a predicted model of the same protein · chain I against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.